242 related articles for article (PubMed ID: 28819935)
1. Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations.
Girard R; Zeineddine HA; Fam MD; Mayampurath A; Cao Y; Shi C; Shenkar R; Polster SP; Jesselson M; Duggan R; Mikati AG; Christoforidis G; Andrade J; Whitehead KJ; Li DY; Awad IA
Transl Stroke Res; 2018 Feb; 9(1):34-43. PubMed ID: 28819935
[TBL] [Abstract][Full Text] [Related]
2. Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth.
Girard R; Zeineddine HA; Koskimäki J; Fam MD; Cao Y; Shi C; Moore T; Lightle R; Stadnik A; Chaudagar K; Polster S; Shenkar R; Duggan R; Leclerc D; Whitehead KJ; Li DY; Awad IA
Circ Res; 2018 Jun; 122(12):1716-1721. PubMed ID: 29720384
[TBL] [Abstract][Full Text] [Related]
3. Clinical course of untreated thalamic cavernous malformations: hemorrhage risk and neurological outcomes.
Tian KB; Zheng JJ; Ma JP; Hao SY; Wang L; Zhang LW; Wu Z; Zhang JT; Li D
J Neurosurg; 2017 Sep; 127(3):480-491. PubMed ID: 27834594
[TBL] [Abstract][Full Text] [Related]
4. Natural history of cerebral cavernous malformations.
Ene C; Kaul A; Kim L
Handb Clin Neurol; 2017; 143():227-232. PubMed ID: 28552144
[TBL] [Abstract][Full Text] [Related]
5. Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage.
Zeineddine HA; Girard R; Cao Y; Hobson N; Fam MD; Stadnik A; Tan H; Shen J; Chaudagar K; Shenkar R; Thompson RE; McBee N; Hanley D; Carroll T; Christoforidis GA; Awad IA
J Magn Reson Imaging; 2018 Apr; 47(4):1133-1138. PubMed ID: 28791783
[TBL] [Abstract][Full Text] [Related]
6. Proteomics on human cerebral cavernous malformations reveals novel biomarkers in neurovascular dysfunction for the disease pathology.
Jauhiainen S; Onyeogaziri FC; Lazzaroni F; Conze LL; Laakkonen JP; Laham-Karam N; Laakso A; Niemelä M; Rezai Jahromi B; Magnusson PU
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167139. PubMed ID: 38537685
[TBL] [Abstract][Full Text] [Related]
7. Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations.
Girard R; Fam MD; Zeineddine HA; Tan H; Mikati AG; Shi C; Jesselson M; Shenkar R; Wu M; Cao Y; Hobson N; Larsson HBW; Christoforidis GA; Awad IA
J Neurosurg; 2017 Jul; 127(1):102-110. PubMed ID: 27494817
[TBL] [Abstract][Full Text] [Related]
8. The association between high VEGF levels and multiple probable punctuate cavernous malformations.
Abe T; Morishige M; Ooba H; Kamida T; Fujiki M; Kobayashi H; Sakoda T; Kimba Y
Acta Neurochir (Wien); 2009 Jul; 151(7):855-9. PubMed ID: 19479188
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity.
Choquet H; Pawlikowska L; Nelson J; McCulloch CE; Akers A; Baca B; Khan Y; Hart B; Morrison L; Kim H;
Cerebrovasc Dis; 2014; 38(6):433-40. PubMed ID: 25472749
[TBL] [Abstract][Full Text] [Related]
10. A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH).
Girard R; Li Y; Stadnik A; Shenkar R; Hobson N; Romanos S; Srinath A; Moore T; Lightle R; Shkoukani A; Akers A; Carroll T; Christoforidis GA; Koenig JI; Lee C; Piedad K; Greenberg SM; Kim H; Flemming KD; Ji Y; Awad IA
Neurosurgery; 2021 Feb; 88(3):686-697. PubMed ID: 33469662
[TBL] [Abstract][Full Text] [Related]
11. Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice.
Lopez-Ramirez MA; Pham A; Girard R; Wyseure T; Hale P; Yamashita A; Koskimäki J; Polster S; Saadat L; Romero IA; Esmon CT; Lagarrigue F; Awad IA; Mosnier LO; Ginsberg MH
Blood; 2019 Jan; 133(3):193-204. PubMed ID: 30442679
[TBL] [Abstract][Full Text] [Related]
12. Hemorrhage, Seizures, and Dynamic Changes of Familial versus Nonfamilial Cavernous Malformation: Systematic Review and Meta-analysis.
Taslimi S; Ku JC; Modabbernia A; Macdonald RL
World Neurosurg; 2019 Jun; 126():241-246. PubMed ID: 30851471
[TBL] [Abstract][Full Text] [Related]
13. Cavernous Malformation Hemorrhagic Presentation at Diagnosis Associated with Low 25-Hydroxy-Vitamin D Level.
Flemming KD; Kumar S; Brown RD; Singh RJ; Whitehead K; McCreath L; Lanzino G
Cerebrovasc Dis; 2020; 49(2):216-222. PubMed ID: 32348981
[TBL] [Abstract][Full Text] [Related]
14. Clinical features of cerebral cavernous malformations patients with KRIT1 mutations.
Denier C; Labauge P; Brunereau L; Cavé-Riant F; Marchelli F; Arnoult M; Cecillon M; Maciazek J; Joutel A; Tournier-Lasserve E; ;
Ann Neurol; 2004 Feb; 55(2):213-20. PubMed ID: 14755725
[TBL] [Abstract][Full Text] [Related]
15. Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation disease.
Girard R; Khanna O; Shenkar R; Zhang L; Wu M; Jesselson M; Zeineddine HA; Gangal A; Fam MD; Gibson CC; Whitehead KJ; Li DY; Liao JK; Shi C; Awad IA
Biomark Med; 2016; 10(3):255-64. PubMed ID: 26861901
[TBL] [Abstract][Full Text] [Related]
16. The natural history of cerebral cavernous malformations.
Kondziolka D; Lunsford LD; Kestle JR
J Neurosurg; 1995 Nov; 83(5):820-4. PubMed ID: 7472549
[TBL] [Abstract][Full Text] [Related]
17. Circulating Blood Prognostic Biomarker Signatures for Hemorrhagic Cerebral Cavernous Malformations (CCMs).
Croft J; Grajeda B; Aguirre LA; Abou-Fadel JS; Ellis CC; Estevao I; Almeida IC; Zhang J
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731959
[TBL] [Abstract][Full Text] [Related]
18. Long-term seizure outcomes following resection of supratentorial cavernous malformations.
Kwon CS; Sheth SA; Walcott BP; Neal J; Eskandar EN; Ogilvy CS
Clin Neurol Neurosurg; 2013 Nov; 115(11):2377-81. PubMed ID: 24075713
[TBL] [Abstract][Full Text] [Related]
19. The Influence of Physical Activity on Cavernous Malformation Hemorrhage.
Joseph NK; Kumar S; Lanzino G; Flemming KD
J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104629. PubMed ID: 32147026
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal changes in seizure outcomes after resection of cerebral cavernous malformations in patients presenting with seizures: a long-term follow-up of 46 patients.
Kim J; Kim CH; Chung CK
Acta Neurochir (Wien); 2014 Aug; 156(8):1539-47; discussion 1546-7. PubMed ID: 24829156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
